Answers are grounded in this paper and cite their sources.
Objective To investigate the expression of miR-29c-5p in patients with gallbladder cancer (GBC) and to analyze the association of the expression with the clinicopathologic characteristics. Methods The expression levels of miR-29c-5p in 40 patients with GBC along with their matched adjacent tissues were detected by using stem-loop real-time reverse transcription-polymerase chain reaction (qRT-qPCR). The relations of miR-29c-5p expression with the clinicopathologic factors and prognosis of GBC patients were analyzed. Results Compared with tumor-adjacent tissue, the miR-29c-5p expression in GBC was significantly downregulated (Z=-2.521, P=0.008). The expression of miR-29c-5p was closely associated with lynphatic metastasis (χ2=15.140, P 0.05). The average survival period of low and high expression of miR-29c-5p were 7.2 months and 20.2 months. The one-year and three-year survival rate of patients with low expression of miR-29c-5p were significantly lower than those with high levels (32.0%, 16.0% vs 55.7%, 33.4%)(P=0.040). Low miR-29c-5p expression is not risk factor affecting the survival of GBC patients (P=0.974). Conclusions The miR-29c-5p expression is downregulated in GBC tissue, which probably may be associated with the metastasis of GBC, and low miR-29c-5p expression may predict an unfavorable outcome.
No takes yet. Share an insight, caveat, or question.
Shu et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: